Biocept, Inc.
Hedge Funds Holdings
Last updated:
Biocept, Inc.‘s stocks are currently a part of 14 hedge funds’ portfolios, which represents 2.96% of the total amount of its stocks outstanding. This makes up a total of 502.28K shares of Biocept, Inc.. Compared to the previous quarter, the number fell by -64.62% or -917.57K shares fewer. As for the holding position changes, 21.43% (3) of current hedge fund investors increased the number of shares held, 21.43% (3) of current holders sold a part of the shares held, and 35.71% (5) closed the holdings completely. 4 hedge funds are new holders of Biocept, Inc. stock in Q1 2023, it is 28.57% of total holders.
Hedge funds holding Biocept (Q2 2018 – Q1 2023)
| Q2 2018 | 20 |
|---|---|
| Q3 2018 | 7 |
| Q4 2018 | 11 |
| Q1 2019 | 16 |
| Q2 2019 | 10 |
| Q3 2019 | 11 |
| Q4 2019 | 12 |
| Q1 2020 | 15 |
| Q2 2020 | 17 |
| Q3 2020 | 13 |
| Q4 2020 | 18 |
| Q1 2021 | 18 |
| Q2 2021 | 20 |
| Q3 2021 | 25 |
| Q4 2021 | 32 |
| Q1 2022 | 26 |
| Q2 2022 | 25 |
| Q3 2022 | 24 |
| Q4 2022 | 25 |
| Q1 2023 | 14 |
Hedge funds changes in Biocept positions (Q2 2018 – Q1 2023)
| Q2 2018 | 5 | 5 | 5 | 7 | -2 |
|---|---|---|---|---|---|
| Q3 2018 | 7 | 0 | 0 | 20 | -20 |
| Q4 2018 | 5 | 2 | 2 | 1 | 1 |
| Q1 2019 | 10 | 2 | 1 | 5 | -2 |
| Q2 2019 | 0 | 3 | 0 | 6 | 1 |
| Q3 2019 | 4 | 0 | 1 | 3 | 3 |
| Q4 2019 | 7 | 0 | 0 | 6 | -1 |
| Q1 2020 | 7 | 4 | 0 | 4 | 0 |
| Q2 2020 | 7 | 6 | 1 | 5 | -2 |
| Q3 2020 | 13 | 0 | 0 | 17 | -17 |
| Q4 2020 | 8 | 2 | 5 | 3 | 0 |
| Q1 2021 | 6 | 5 | 2 | 6 | -1 |
| Q2 2021 | 6 | 6 | 3 | 4 | 1 |
| Q3 2021 | 10 | 4 | 7 | 5 | -1 |
| Q4 2021 | 12 | 8 | 5 | 5 | 2 |
| Q1 2022 | 2 | 8 | 9 | 7 | 0 |
| Q2 2022 | 5 | 7 | 9 | 6 | -2 |
| Q3 2022 | 3 | 1 | 7 | 4 | 9 |
| Q4 2022 | 6 | 2 | 8 | 5 | 4 |
| Q1 2023 | 4 | 3 | 3 | 5 | -1 |
Hedge funds changes in Biocept stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 160,000 | 211,000 |
| Q1 2021 | 937,000 | 1,783,000 |
| Q2 2021 | 428,000 | 1,308,000 |
| Q3 2021 | 649,000 | 290,000 |
| Q4 2021 | 616,000 | 176,000 |
| Q1 2022 | 394,000 | 113,000 |
| Q2 2022 | 189,000 | 13,000 |
| Q3 2022 | 110,000 | 4,000 |
| Q4 2022 | 29,468 | 10,106 |
| Q1 2023 | 0 | 0 |